Last updated on: 13/09/2012
Name of organisation
1) Department/Research group
2) Organisation/affiliationCSD Medical Research
Short Name in the inventoryCSD MR France
Administrative Contact
Title Dr
Last name Kempf
First name Christian
Address line 190-92 route de la reine
Address line 2
Address line 3
CityBoulogne Billancourt
Postcode
CountryFrance
Phone number (incl. country code)33149098760
Alternative phone number
Fax number (incl. country code)
Scientific Contact
Title Dr
Last name Kempf
First name Christian
Address line 190-92 route de la reine
Address line 2
Address line 3
CityBoulogne Billancourt
Postcode
CountryFrance
Phone number (incl. country code)33149098760
Alternative phone number
Fax number (incl. country code)
2. Description
CSD Medical Research is widely experienced in patient data for the healthcare industry, through numerous market researches and epidemiological studies.
CSD tools include:
• The Longitudinal Patient Databases (LPD) from Primary Care Physicians (and some panels of Specialists )
• The possibility to program additional screens to the electronic medical records of patients included into a study in the doctor’s daily practice software so that the physician can complete them on a regular basis
• The INES software, including many features like electronic CRF, data management, investigators CRM, distant study management tool
The CSD proprietary permanent Longitudinal Patient Databases (LPD) contains full actual prescription data, patient profiles and other information collected by the office-based GPs from our panel GP group during the patient consultation into his medical record. Those records are based on the usual practice of the physician.
3. Category
For profit organisation
4. Available resources
In houseVia Contacts/Network
database expertise
Yes
No
project management expertise
Yes
No
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Disorders of the central nervous system
Ear, nose and oropharynx disorders
Endocrine disorders
Eye disorders
Gynaecology
Immunological products and vaccines
Infectious diseases
Malignant disease
Musculoskeletal and joint diseases
Nutrition and blood
Osteoporosis
Psychiatry
Renal impairment
Respiratory diseases
Skin disorders
Urinary tract disorders
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
Interventional Clinical Trial
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Less than 5
Number of patients/respondents involved in the study(ies)
Between 150 and 1499
8. Access to data collection resources
Capacity to conduct face-to-face interviews
No
Electronic data capture systems
Yes
System used:
eCRF (in house software)
Interactive voice response systems
No
Call centre
Yes
9. Experience in secondary research and meta-analysis
No
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
THIN265
Cegedim European LPDs100
11. Registries established by centre
Drug RegistryAtrial fibrilation
12. Experience in collaboration in a study team
None
13. Current involvement in research networks
None
14. Interest in research opportunities which are funded
By pharmaceutical companies
By charities
By government
By research councils
By EU funding schemes
15. Interest in contract research only if free to publish results
No
16. Selected publications of the last 5 calendar years
ReferenceLink to web-publication
Maguire A, Blak B, Haynes K. Parameterizing Risk‐Benefit Models from Primary Care Data: Recurrence and Exacerbation. Pharmacoepidemiology and Drug Safety, (19):S1‐S347, 2010.
Keenan H T, Hall G C, Marshall S W. Early head injury and attention deficit hyperactivity disorder: retrospective cohort study. British Medical Journal. 2008 Nov 6;337:a1984. doi: 10.1136/bmj.a1984.
Laforest L, Schwalm MS, Dufour M, Broquet M, Bourke A, Van Ganse E. Comparison of Prescribing Patterns for Asthma in Five European Countries. Pharmacoepidemiology and Drug Safety, (19): S1‐S347, 2010.
Gonzalez-Perez A, Schlienger RG, Rodríguez LA.Acute Pancreatitis in Association With Type 2 Diabetes and Antidiabetic Drugs: A population-based cohort study. Diabetes Care. 2010 Dec;33(12):2580-5.
Maguire A, Blak B T and Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiology and Drug Safety. 2009 Jan;18(1):76-83
